← Back to all stories
HealthExercise levels for major heart protection

Study links 560-610 minutes of weekly moderate-to-vigorous exercise to major reductions in heart attack and stroke risk

An observational study of over 17,000 UK Biobank participants found that meeting the standard 150 minutes per week of moderate-to-vigorous physical activity was associated with only an 8-9% lower risk of cardiovascular events. Achieving a greater than 30% risk reduction required roughly 560 to 610 minutes weekly, or three to four times current guidelines, with lower-fitness individuals needing slightly more activity for equivalent benefits. Researchers suggest future guidelines could distinguish minimum protection from optimal levels and personalize targets by fitness.

Key points

  • 150 minutes weekly linked to modest 8-9% lower cardiovascular risk across fitness levels.
  • Over 30% risk reduction associated with 560-610 minutes of moderate-to-vigorous activity per week.
  • Less fit people needed 30-50 extra minutes weekly for similar benefits; only 12% reached higher volume.
2h ago2 min read7 SourcesAI-generated — how does this work?

Why this is uncovered

Covered by health specialists, ScienceDaily, The Guardian and BMJ press materials, with limited broader mainstream pickup beyond initial May 2026 reports.


This article was generated automatically from primary sources and has not been reviewed by a human editor. Verify claims before sharing.

Adults may need substantially more weekly exercise than current public health guidelines recommend to achieve major reductions in the risk of heart attack, stroke and other cardiovascular events, according to an observational study published in the British Journal of Sports Medicine.

Researchers from Macao Polytechnic University analyzed data from 17,088 UK Biobank participants (average age 57; 56% female; 96% white) enrolled between 2013 and 2015. Participants wore wrist devices for seven consecutive days to measure moderate-to-vigorous physical activity (MVPA) and completed a cycling test to estimate cardiorespiratory fitness via VO2 max. The analysis adjusted for factors including smoking, alcohol use, diet, body mass index, resting heart rate and blood pressure (BMJ Group).

Over a median follow-up of about 7.8–7.85 years, 1,233 incident cardiovascular events occurred, including 874 cases of atrial fibrillation, 156 myocardial infarctions, 111 heart failure cases and 92 strokes (ScienceDaily; British Journal of Sports Medicine abstract).

Meeting the widely recommended minimum of 150 minutes of MVPA per week—activities such as brisk walking, running or cycling—was associated with a modest 8–9% reduction in cardiovascular risk. This association held similarly across fitness levels (Healthline; The Guardian).

Substantial protection, defined by the researchers as a greater than 30% risk reduction, was linked to 560–610 minutes of MVPA per week—roughly three to four times the current guideline and equivalent to about 9–10 hours. Only 12% of study participants reached this level (BMJ Group; Medical News Today).

Fitness level influenced the volume needed. People with the lowest cardiorespiratory fitness required approximately 30–50 additional minutes per week compared with the fittest participants for equivalent benefits. For a 20% risk reduction, those at lowest fitness needed about 370 minutes weekly versus 340 minutes for those at highest fitness (ScienceDaily; The Guardian).

The study also used Mendelian randomisation analyses, finding some genetic evidence supporting a protective role for higher cardiorespiratory fitness against heart failure, though evidence for physical activity traits was weaker (British Journal of Sports Medicine abstract).

As an observational study, it cannot prove causation. Limitations noted by the authors include that participants may have been healthier and fitter than the general population, fitness was estimated rather than directly measured, and the analysis did not fully assess sedentary time or lower-intensity activity (BMJ Group).

The researchers concluded that current guidelines offer a robust universal minimum for basic cardiovascular protection but that future guidance may need to differentiate this from higher volumes associated with optimal risk reduction, potentially incorporating personalized targets based on fitness level. “Future guidelines may need to differentiate between the minimal moderate to vigorous exercise volume required for a basic safety margin and the substantially higher volumes necessary for optimal cardiovascular risk reduction,” they wrote (ScienceDaily).

Current recommendations from bodies such as the American Heart Association and World Health Organization advise at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic activity weekly for adults, with additional benefits noted at higher volumes up to 300 minutes (American Heart Association).

Share:X / TwitterLinkedIn

Want to respond?

The Uncovered has no comment section by design — we don't host or moderate discussions. If you still want to read along or join in, you can do so over Nostr, an open protocol where your replies live on your own key instead of on our server. Install NostrComments for Chrome or Firefox and the discussion appears on top of this page. Works on desktop and on Firefox for Android.

Open source, no tracking, free.

More in Health

UC San Diego study links teenage cannabis initiation to slower gains in memory and thinking skills

A large longitudinal analysis of more than 11,000 U.S. youth in the Adolescent Brain Cognitive Development Study found that teens who began using cannabis showed restricted improvement over time in memory, attention, language, and processing speed compared with non-users. THC exposure was specifically associated with worse episodic memory trajectories. The findings, published in Neuropsychopharmacology, come from researchers at the University of California San Diego who combined self-reports with toxicological testing.

9 Aug 2026

Nagoya University researchers find local complement C3 enhances cancer immunotherapy response

Scientists at Nagoya University have shown that complement protein C3 produced inside tumors, rather than circulating in the blood, improves the effectiveness of immune checkpoint blockade therapy by limiting immunosuppressive myeloid cells. The findings, published in Nature Communications, were supported by mouse experiments and analysis of human lung cancer samples. Mimicking this local C3 effect restored treatment sensitivity in previously resistant tumors in mice.

9 Aug 2026

Landmark trial finds acetaminophen and ibuprofen safe for babies in first year with no link to eczema or bronchiolitis

A randomised controlled trial of nearly 4,000 New Zealand infants found no significant difference in rates of eczema or bronchiolitis between those given acetaminophen (paracetamol) and those given ibuprofen for fever or pain in the first year of life. Serious adverse events were rare and unrelated to either medication. The results, published in The Lancet Child & Adolescent Health, form the first-year findings of the ongoing PIPPA Tamariki study.

7 Aug 2026